Source: Bmc cancer. Unidade: FM
Subjects: CARCINOMA HEPATOCELULAR, CITOTOXINAS, INIBIDORES DE ENZIMAS, TAXA DE SOBREVIVÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FONSECA, Leonardo Gomes da et al. Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib. Bmc cancer, v. 18, 2018Tradução . . Disponível em: https://doi.org/10.1186/s12885-018-5173-0. Acesso em: 04 nov. 2024.APA
Fonseca, L. G. da, Carrilho, F. J., Hoff, P. M., Marta, G. N., Braghiroli, M. I. F. M., Chagas, A. L., & Sabbaga, J. (2018). Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib. Bmc cancer, 18. doi:10.1186/s12885-018-5173-0NLM
Fonseca LG da, Carrilho FJ, Hoff PM, Marta GN, Braghiroli MIFM, Chagas AL, Sabbaga J. Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib [Internet]. Bmc cancer. 2018 ; 18[citado 2024 nov. 04 ] Available from: https://doi.org/10.1186/s12885-018-5173-0Vancouver
Fonseca LG da, Carrilho FJ, Hoff PM, Marta GN, Braghiroli MIFM, Chagas AL, Sabbaga J. Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib [Internet]. Bmc cancer. 2018 ; 18[citado 2024 nov. 04 ] Available from: https://doi.org/10.1186/s12885-018-5173-0
